共 50 条
- [31] Bendamustine-120 plus rituximab therapy for relapsed or refractory follicular lymphoma: a multicenter phase II studyANNALS OF HEMATOLOGY, 2019, 98 (09) : 2131 - 2138Sakai, R.Ohmachi, K.Sano, F.Watanabe, R.Takahashi, H.Takasaki, H.Tanaka, M.Hattori, Y.Kimura, H.Takimoto, M.Tachibana, T.Tanaka, E.Ishii, Y.Ishiyama, Y.Hagihara, M.Miyazaki, K.Yamamoto, K.Tomita, N.Ando, K.
- [32] Bendamustine Treatment in Refractory or Relapsed T Cell Lymphomas: A Retrospective Multicenter StudyBLOOD, 2015, 126 (23)Reboursiere, EmilieLe Bras, FabienMorschhauser, FranckGyan, EmmanuelClavert, AlineMalak, SandraSibon, DavidDamge, MarionGardin, ClaudeFornecker, Luc-MatthieuGaridi, RedaTricot, SabineHouot, RochJoly, BertrandAbarah, WajedChoufi, BachraPham, Anne-dominiqueChantepie, Sylvain P.Fruchart, ChristopheGac, Anne-ClaireOllivier, CatherineMarin, EmilieSafar, ViolaineParcelier, AnneMaisonneuve, HerveBachy, EmmanuelCartron, GuillaumeJaccard, ArnaudTournilhac, OlivierRossi, CedricPerrot, AuroreMartignoles, Jean-AlainTilly, HerveDamaj, Gandhi
- [33] AN INTERNATIONAL MULTICENTER PHASE I/II STUDY OF BRENTUXIMAB VEDOTIN AND BENDAMUSTINE IN PATIENTS WITH HEAVILY TREATED RELAPSED OR REFRACTORY HODGKIN LYMPHOMA AND ANAPLASTIC LARGE T-CELL LYMPHOMA DEMONSTRATES MARKED DURABLE RESPONSESHAEMATOLOGICA, 2016, 101 : 47 - 47O'Connor, O. A.Sawas, A.Connors, J. M.Turenne, I.Rojas, C.Lichtenstein, R.Deng, C.Amengual, J. E.Villa, D.Crump, M.Kuruvilla, J.
- [34] Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphomaJOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) : 4867 - 4874Fisher, Richard I.Bernstein, Steven H.Kahl, Brad S.Djulbegovic, BenjaminRobertson, Michael J.de Vos, SvenEpner, ElliotKrishnan, AmritaLeonard, John P.Lonial, SagarStadtmauer, Edward A.O'Connor, Owen A.Shi, HongliangBoral, Anthony L.Goy, Andre
- [35] Translational Data from a multicenter Phase II Study on Dimethyl Fumarate Therapy in Patients with relapsed and refractory cutaneous T-Cell LymphomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2024, 22 : 9 - 10Melchers, S.Albrecht, J. D.Zhao, J.Moessinger, K.de la Torre, C.Sticht, C.Guelow, K.Schuerch, C. M.Krammer, P. H.Nicolay, J. P.
- [36] Results from a multicenter, open-label, pivotal phase II study of chidamide in relapsed or refractory peripheral T-cell lymphomaANNALS OF ONCOLOGY, 2015, 26 (08) : 1766 - 1771Shi, Y.Dong, M.Hong, X.Zhang, W.Feng, J.Zhu, J.Yu, L.Ke, X.Huang, H.Shen, Z.Fan, Y.Li, W.Zhao, X.Qi, J.Huang, H.Zhou, D.Ning, Z.Lu, X.
- [37] Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T-cell lymphomaCANCER SCIENCE, 2017, 108 (10): : 2061 - 2068Maruyama, DaiNagai, HirokazuMaeda, YoshinobuNakane, TakahikoShimoyama, TatsuNakazato, TomonoriSakai, RikaIshikawa, TakayukiIzutsu, KojiUeda, RyuzoTobinai, Kensei
- [38] A phase II study of bortezomib in patients with relapsed or refractory aggressive adult T-cell leukemia/lymphomaCANCER SCIENCE, 2015, 106 (09): : 1219 - 1223Ishitsuka, KenjiUtsunomiya, AtaeKatsuya, HirooTakeuchi, ShogoTakatsuka, YoshifusaHidaka, MichihiroSakai, TatsunoriYoshimitsu, MakotoIshida, TakashiTamura, Kazuo
- [39] Multicenter Phase II Study of Lenalidomide in Patients with Relapsed Adult T-Cell Leukemia-LymphomaBLOOD, 2015, 126 (23)Fujiwara, HiroshiIshida, TakashiNosaka, KisatoTaira, NaoyaAbe, YasunobuImaizumi, YoshitakaMoriuchi, YukiyoshiJo, TatsuroIshizawa, KenichiTobinai, KenseiTsukasaki, KunihiroIto, ShigekiYoshimitsu, MakotoOtsuka, MakiOgura, MichinoriMidorikawa, ShuichiRuiz, WandaOhtsu, Tomoko
- [40] Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial.JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)Berenson, J. R.Yellin, O.Bessudo, A.Boccia, R.Noga, S.Gravenor, D.Patel-Donnelly, D.Siegel, R. S.Kewalramani, T.Gorak, E. J.Swift, R.Bensen-Kennedy, D.